This bill requires the Food and Drug Administration to issue guidance that addresses using alternative statistical methods, including adaptive trial design and Bayesian methods, in clinical trials and in the development and review of drugs and biological products.
| Action Date | Type | Text | Source |
|---|---|---|---|
| 2015-05-22 | Committee | Referred to the Subcommittee on Health. | House committee actions |
| 2015-05-19 | IntroReferral | Referred to the House Committee on Energy and Commerce. | House floor actions |
| 2015-05-19 | IntroReferral | Introduced in House | Library of Congress |